Osteoprotegerin is associated with major bleeding but not with cardiovascular outcomes in patients with acute coronary syndromes-insights from the platelet inhibition and patient outcomes (PLATO) trial

Category Primary study
JournalCirculation
Year 2016
This article has no abstract
Epistemonikos ID: 90a35b805db50095ae8e0c49f14c2e1afc7716dd
First added on: Feb 08, 2025